Expanded HILUS Trial: A Pooled Analysis of Risk Factors for Toxicity From Stereotactic Body Radiation Therapy of Central and Ultracentral Lung Tumors.

Autor: Lindberg S; Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden; Theme Cancer, Department of Head, Neck, Lung and Skin Tumors, Karolinska University Hospital, Stockholm, Sweden. Electronic address: sara.lindberg@ki.se., Grozman V; Section of Thoracic Radiology, Department of Imaging and Physiology, Karolinska University Hospital, Stockholm, Sweden; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden., Karlsson K; Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden; Section of Radiotherapy Physics and Engineering, Department of Medical Radiation Physics and Nuclear Medicine, Karolinska University Hospital, Stockholm, Sweden., Onjukka E; Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden; Section of Radiotherapy Physics and Engineering, Department of Medical Radiation Physics and Nuclear Medicine, Karolinska University Hospital, Stockholm, Sweden., Lindbäck E; Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden; Section of Radiotherapy Physics and Engineering, Department of Medical Radiation Physics and Nuclear Medicine, Karolinska University Hospital, Stockholm, Sweden., Jirf KA; Theme Cancer, Department of Head, Neck, Lung and Skin Tumors, Karolinska University Hospital, Stockholm, Sweden., Lax I; Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden; Theme Cancer, Department of Head, Neck, Lung and Skin Tumors, Karolinska University Hospital, Stockholm, Sweden., Wersäll P; Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden; Section of Radiotherapy, Department of Cancer, Karolinska University Hospital, Stockholm, Sweden., Persson GF; Section of Radiotherapy, Department of Oncology, Rigshospitalet, Copenhagen, Denmark; Department of Oncology, Herlev-Gentofte Hospital, Herlev, Denmark; Department of Clinical Medicine, Copenhagen University Hospital, Copenhagen, Denmark., Josipovic M; Section of Radiotherapy, Department of Oncology, Rigshospitalet, Copenhagen, Denmark; Department of Clinical Medicine, Copenhagen University Hospital, Copenhagen, Denmark., Khalil AA; Department of Clinical Medicine, Faculty of Health Sciences, Aarhus University, Aarhus, Denmark; Department of Oncology, Aarhus University Hospital, Aarhus, Denmark., Møller DS; Department of Clinical Medicine, Faculty of Health Sciences, Aarhus University, Aarhus, Denmark; Department of Oncology, Aarhus University Hospital, Aarhus, Denmark., Hoffmann L; Department of Clinical Medicine, Faculty of Health Sciences, Aarhus University, Aarhus, Denmark; Department of Oncology, Aarhus University Hospital, Aarhus, Denmark., Knap MM; Department of Clinical Medicine, Faculty of Health Sciences, Aarhus University, Aarhus, Denmark., Nyman J; Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden; Department of Oncology, Sahlgrenska University Hospital, Gothenburg, Sweden., Drugge N; Department of Therapeutic Radiation Physics, Sahlgrenska University Hospital, Gothenburg, Sweden., Bergström P; Department of Oncology, Northern Sweden University Hospital, Umeå, Sweden., Olofsson J; Department of Oncology, Northern Sweden University Hospital, Umeå, Sweden., Rogg LV; Department of Oncology, Oslo University Hospital, Oslo, Norway., Hagen RK; Department of Oncology, Oslo University Hospital, Oslo, Norway., Frøland AS; Department of Oncology, Oslo University Hospital, Oslo, Norway., Ramberg C; Department of Medical Physics, Oslo University Hospital, Oslo, Norway., Kristiansen C; Department of Oncology, Vejle Hospital, University Hospital of Southern Denmark, Vejle, Denmark., Jeppesen SS; Department of Oncology, Odense University Hospital, Odense, Denmark; Institute of Clinical Research, University of Southern Denmark, Odense, Denmark., Nielsen TB; Laboratory of Radiation Physics, Odense University Hospital, Odense, Denmark., Lödén B; Oncology Department, Central Hospital in Karlstad, Karlstad, Sweden., Rosenbrand HO; Oncology Department, Central Hospital in Karlstad, Karlstad, Sweden., Engelholm S; Department of Hematology, Oncology and Radiation Physics, Skåne University Hospital, Lund, Sweden., Haraldsson A; Department of Hematology, Oncology and Radiation Physics, Skåne University Hospital, Lund, Sweden., Billiet C; Department of Radiation Oncology, Iridium Netwerk, Wilrijk, University of Antwerp, Antwerp, Belgium., Lewensohn R; Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden; Theme Cancer, Department of Head, Neck, Lung and Skin Tumors, Karolinska University Hospital, Stockholm, Sweden., Lindberg K; Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden; Theme Cancer, Department of Head, Neck, Lung and Skin Tumors, Karolinska University Hospital, Stockholm, Sweden.

Publikováno v: International journal of radiation oncology, biology, physics [Int J Radiat Oncol Biol Phys] 2023 Dec 01; Vol. 117 (5), pp. 1222-1231. Date of Electronic Publication: 2023 Jul 08.

How to improve loco-regional control in stages IIIa–b NSCLC?: Results of a three-armed randomized trial from the Swedish Lung Cancer Study Group

Autor: Nyman, J., Friesland, S., Hallqvist, A., Seke, M., Bergström, S., Thaning, L., Lödén, B., Sederholm, C., Wagenius, G.

Publikováno v: In Lung Cancer 2009 65(1):62-67

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Mature results from a Swedish comparison study of conventional versus accelerated radiotherapy in head and neck squamous cell carcinoma - The ARTSCAN trial.

Autor: Zackrisson B; Department of Radiation Sciences - Oncology, Umeå University, Sweden. Electronic address: bjorn.zackrisson@umu.se., Kjellén E; Department of Oncology and Radiation Physics, Skåne University Hospital, Lund University, Sweden., Söderström K; Department of Radiation Sciences - Oncology, Umeå University, Sweden., Brun E; Department of Oncology and Radiation Physics, Skåne University Hospital, Lund University, Sweden., Nyman J; Department of Oncology, Sahlgrenska University Hospital, Gothenburg, Sweden., Friesland S; Department of Oncology, Karolinska University Hospital, Stockholm, Sweden., Reizenstein J; Department of Oncology, Örebro University Hospital, Sweden., Sjödin H; Department of Oncology, Karolinska University Hospital, Stockholm, Sweden., Ekberg L; Department of Oncology and Radiation Physics, Skåne University Hospital, Lund University, Sweden., Lödén B; Department of Oncology, Central Hospital, Karlstad, Sweden., Franzén L; Department of Radiation Sciences - Oncology, Umeå University, Sweden., Ask A; Department of Oncology and Radiation Physics, Skåne University Hospital, Lund University, Sweden., Wickart-Johansson G; Department of Oncology, Karolinska University Hospital, Stockholm, Sweden., Lewin F; Department of Oncology, Ryhov Hospital, Jönköping, Sweden., Björk-Eriksson T; Department of Oncology, Sahlgrenska University Hospital, Gothenburg, Sweden., Lundin E; Department of Oncology, Örebro University Hospital, Sweden., Dalianis T; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden., Wennerberg J; Department of ORL/Head & Neck Surgery, Skåne University Hospital, Lund, Sweden., Johansson KA; Department of Radiation Physics, Sahlgrenska University Hospital, Gothenburg, Sweden., Nilsson P; Department of Oncology and Radiation Physics, Skåne University Hospital, Lund University, Sweden.

Publikováno v: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology [Radiother Oncol] 2015 Oct; Vol. 117 (1), pp. 99-105. Date of Electronic Publication: 2015 Sep 29.